Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
about
Unusual DNA binding modes for metal anticancer complexes.Osmium(IV) complexes with 1H- and 2H-indazoles: tautomer identity versus spectroscopic properties and antiproliferative activity.Hypoxia-selective inhibition of angiogenesis development by NAMI-A analogues.Anticancer activity of metal complexes: involvement of redox processes.pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents.Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential.Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019.Electron transfer in dye-sensitised semiconductors modified with molecular cobalt catalysts: photoreduction of aqueous protons.Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs.Facile total synthesis of lysicamine and the anticancer activities of the RuII, RhIII, MnII and ZnII complexes of lysicamineInhibitory effects of NAMI-A-like ruthenium complexes on prion neuropeptide fibril formation.Enhancing H2 evolution performance of an immobilised cobalt catalyst by rational ligand design.New RuII (arene) complexes with halogen-substituted bis- and tris(pyrazol-1-yl)borate ligands.{Ru(CO)x}-Core complexes with benzimidazole ligands: synthesis, X-ray structure and evaluation of anticancer activity in vivo.Crystal structures and DFT calculations of new chlorido-dimethylsulfoxide-M(III) (M = Ir, Ru, Rh) complexes with the N-pyrazolyl pyrimidine donor ligand: kinetic vs. thermodynamic isomers.Coordination Behavior of Ni2+, Cu2+, and Zn2+ in Tetrahedral 1-Methylimidazole Complexes: A DFT/CSD Study.Osmium(vi) nitrido complexes bearing azole heterocycles: a new class of antitumor agents
P2860
Q34071185-C269ED3D-89AC-43C1-BAC1-13EEE588FBC6Q36103771-15BCA254-72AC-49AA-A555-12180028F40BQ37424157-04F548C1-621D-455A-BFEF-AA0307896302Q37833099-6A401EB5-8C01-46AD-8266-7FDF3C24C9FEQ38695106-B697921D-BA88-4F61-94C8-7235D88CB15EQ38941379-145DB8F7-3AC5-41BD-A266-B94DA62C9D21Q39517558-DD27CD45-40BE-4A2C-8007-4B2CD55FFC74Q39542743-979E3400-EA2C-45A8-A262-C177BDD91DF8Q40064331-AEB39865-AD11-406B-A3B2-C06FE9826704Q41708811-300E9DF0-9504-4E70-A69E-1A684A85F970Q42174365-3E0ED3C8-EEFB-4303-99A5-B74BC061CE98Q46265270-6B637BAC-1058-4066-B868-4BFD30894842Q46921107-90FEEBE1-2E18-4F8F-A62E-F511D1AC7EC1Q48229155-AE843D8B-977F-45FE-86E9-1E8CC124D857Q48608290-C4CED173-6786-4E0E-B484-5F320097D39FQ55190923-2262F713-CB79-4C60-B560-686E94E8278DQ58214102-7B6B19E1-DFDE-46E2-88B2-7AFBF1147457
P2860
Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Tuning of redox potentials for ...... ole, 1,2,4-triazole, indazole.
@en
Tuning of redox potentials for ...... ole, 1,2,4-triazole, indazole.
@nl
type
label
Tuning of redox potentials for ...... ole, 1,2,4-triazole, indazole.
@en
Tuning of redox potentials for ...... ole, 1,2,4-triazole, indazole.
@nl
prefLabel
Tuning of redox potentials for ...... ole, 1,2,4-triazole, indazole.
@en
Tuning of redox potentials for ...... ole, 1,2,4-triazole, indazole.
@nl
P2093
P50
P356
P1433
P1476
Tuning of redox potentials for ...... zole, 1,2,4-triazole, indazole
@en
P2093
Anna Eichinger
Erwin Reisner
Vladimir B Arion
P304
P356
10.1021/IC049479C
P407
P50
P577
2004-11-01T00:00:00Z